Cargando…

Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity

Detalles Bibliográficos
Autor principal:	Li, Gerui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486168/ https://www.ncbi.nlm.nih.gov/pubmed/32926957 http://dx.doi.org/10.1016/j.diabres.2020.108441

Ejemplares similares

Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19
por: Morieri, Mario Luca, et al.
Publicado: (2020)

Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era
por: Aljehani, Faisal A., et al.
Publicado: (2020)

The ARDSnet protocol may be detrimental in COVID-19
por: Tsolaki, Vasiliki, et al.
Publicado: (2020)

No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
por: Li, Gerui, et al.
Publicado: (2020)

Stress Hyperglycemia Ratio may Portend Poor Outcomes in COVID-19
por: Magoon, Rohan, et al.
Publicado: (2021)

Inpatient hyperglycemia: Clinical management needs in teaching hospital()
por: Tamez-Pérez, H.E., et al.
Publicado: (2014)

Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19
por: Li, Gerui
Publicado: (2020)

Hyperglycemia: An independent accompaniment of COVID -19
por: Goel, Anil Kumar, et al.
Publicado: (2021)

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
por: Targher, G., et al.
Publicado: (2020)

Glucocorticoid benefits the ventilatory function of severe/critical COVID-19 patients
por: Xiong, Xiaoming, et al.
Publicado: (2021)

Patterns of Youth Inpatient Psychiatric Admissions Before and After the Onset of the COVID-19 Pandemic
por: Ugueto, Ana M., et al.
Publicado: (2021)

Novel appearance of hyperglycemia/diabetes, associated with COVID-19
por: Ilias, Ioannis
Publicado: (2022)

COVID‐19 and new‐onset arrhythmia
por: Singh, Sandeep, et al.
Publicado: (2020)

Inpatient Hyperglycemia Management and COVID-19
por: Bellido, Virginia, et al.
Publicado: (2020)

Genetic factors may affect the severity of COVID-19
por: Zheng, Zhenzhen, et al.
Publicado: (2021)

COVID-19, Hyperglycemia, and New-Onset Diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2021)

A real‐world study of glucocorticoid treatment in COVID‐19 patients with different disease severities
por: Jiao, Xiaofei, et al.
Publicado: (2020)

Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
por: Ilias, Ioannis, et al.
Publicado: (2020)

Severity and 1-year cumulative incidence of COVID-19 among inpatients with haematologic malignancies
por: Ribeiro Baptista, J.P., et al.
Publicado: (2022)

Risk of detrimental recommendations for cancer pain management
por: Maltoni, Marco, et al.
Publicado: (2021)

Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids
por: Hsieh, Tien-Chan, et al.
Publicado: (2021)

Alcohol Misuse May Increase the Severity of COVID-19 Infections
por: Abbasi-Oshaghi, Ebrahim, et al.
Publicado: (2020)

Importance of hyperglycemia in preoperative, intraoperative and postoperative periods in COVID-19 patients
por: Farahani, Farhad, et al.
Publicado: (2020)

New‐onset vitiligo following COVID‐19 disease
por: Herzum, A., et al.
Publicado: (2022)

Letter to the Editor: Stress Hyperglycemia or Glucokinase Maturity Onset Diabetes of the Young (GCK-MODY) or Both?
por: Doherty-Kirby, Amanda
Publicado: (2023)

New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022)

Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Cancer population may be paradoxically protected from severe manifestations of COVID-19
por: Gallo, Oreste, et al.
Publicado: (2020)

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Uncovering the roots of skin bleaching: Colorism and its detrimental effects
por: Daftary, Karishma, et al.
Publicado: (2022)

Red blood cell transfusion may be more detrimental than anemia for the clinical outcome of patients with severe traumatic brain injury
por: Leal-Noval, Santiago R., et al.
Publicado: (2019)

The Impact of COVID-19 on Inpatient Psychiatry Resident Supervision
por: Coe, William H., et al.
Publicado: (2020)

Persistence of new-onset diabetes in the post-acute phase of COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2022)

New-onset pediatric idiopathic nephrotic syndrome secondary to COVID-19
por: Takagi, Yuhi, et al.
Publicado: (2023)

Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin
por: Uchinuma, Hiroyuki, et al.
Publicado: (2020)

Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
por: Connell, C. M., et al.
Publicado: (2017)

The impact of COVID-19 on inpatient wards at psychiatric hospitals in Japan
por: Usuda, Kentaro, et al.
Publicado: (2021)

Acute new-onset symptomatic seizures in the context of mild COVID-19 infection
por: Gaughan, Maria, et al.
Publicado: (2020)

Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review
por: Brooks, Danielle, et al.
Publicado: (2022)

Management of Glucocorticoid-Induced Hyperglycemia
por: Shah, Parag, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0sv9feba1ip7sbhclkvll1v6aj